Clinical and Epidemiological Profile of Pandemic Influenza A H1N1, H3N2, and Type B in the Southeast of Caspian Sea, Iran

2017 ◽  
Vol 10 (3) ◽  
Author(s):  
Naeme Javid ◽  
Abdolvahab Moradi ◽  
Alijan Tabarraei ◽  
Masoud Bazouri
Keyword(s):  
Pandemic Influenza ◽  
Caspian Sea ◽  
Influenza A ◽  
Type B ◽  
Influenza A H1n1 ◽  
Epidemiological Profile

scholarly journals Clinico-epidemiological profile, pandemic influenza a h1n1/2009 and seasonal influenza, august 2009-march 2013, Himachal Pradesh, India

2016 ◽  
Vol 41 (1) ◽  
pp. 69 ◽  
Author(s):  
VinodKumar Mehta ◽  
Pooja Sharma ◽  
RameshChand Guleria ◽  
SuniteA Ganju ◽  
Digvijay Singh ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Seasonal Influenza ◽  
Himachal Pradesh ◽  
Influenza A H1n1 ◽  
Epidemiological Profile

Viral load and epidemiological profile of patients infected by pandemic influenza a (H1N1) 2009 and seasonal influenza a virus in Southern Brazil

2012 ◽  
Vol 84 (3) ◽  
pp. 371-379 ◽  
Author(s):  
Ana Beatriz Gorini da Veiga ◽  
Nélson Alexandre Kretzmann ◽  
Laura Trevizan Corrêa ◽  
Alessandra Mari Goshiyama ◽  
Tatiana Baccin ◽  
...  
Keyword(s):  
Viral Load ◽  
Influenza A Virus ◽  
Pandemic Influenza ◽  
Influenza A ◽  
Seasonal Influenza ◽  
Southern Brazil ◽  
Influenza A H1n1 ◽  
Epidemiological Profile

scholarly journals Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

2021 ◽  
Author(s):  
José Alberto Choreño-Parra ◽  
Luis Armando Jiménez-Álvarez ◽  
Gustavo Ramírez-Martínez ◽  
Alfredo Cruz-Lagunas ◽  
Mahima Thapa ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Alveolar Epithelium ◽  
Surfactant Protein ◽  
High Serum ◽  
Surfactant Protein D ◽  
Diagnostic Challenge ◽  
Moderate Disease ◽  
Influenza A H1n1 ◽  
Novel Biomarkers

Abstract The differentiation of influenza and COVID-19 could constitute a diagnostic challenge during the ongoing winter due to their clinical similitude. Thus, novel biomarkers that enable distinguishing both diseases are required. Here, we evaluated whether the surfactant protein D (SP-D), a collectin produced at the alveolar epithelium with known immune properties, was useful to differentiate pandemic influenza A(H1N1) from COVID-19 in critically ill patients. Our results revealed high serum SP-D levels in severe pandemic influenza but not COVID-19 patients. This finding was validated in a separate cohort of mechanically ventilated COVID-19 patients who also showed low plasma SP-D levels. However, plasma SP-D levels did not distinguish seasonal influenza from COVID-19 in mild-to-moderate disease. Finally, we found that high serum SP-D levels were associated with mortality and renal failure among severe pandemic influenza cases. Thus, our studies have identified SP-D as a unique biomarker expressed during severe pandemic influenza but not COVID-19.

scholarly journals Ultrastructural and Histopathological Studies of 2009 Pandemic Influenza A (H1N1) Virus

2010 ◽  
Vol 16 (S2) ◽  
pp. 1122-1123
Author(s):  
CS Goldsmith ◽  
MG Metcalfe ◽  
W-J Shieh ◽  
DM Blau ◽  
DC Rollin ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
H1n1 Virus ◽  
Influenza A H1n1 ◽  
Histopathological Studies

Extended abstract of a paper presented at Microscopy and Microanalysis 2010 in Portland, Oregon, USA, August 1 – August 5, 2010.

scholarly journals Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010

2013 ◽  
Vol 19 (3) ◽  
Author(s):  
Rebekah H. Borse ◽  
Sundar S. Shrestha ◽  
Anthony E. Fiore ◽  
Charisma Y. Atkins ◽  
James A. Singleton ◽  
...  
Keyword(s):  
United States ◽  
Pandemic Influenza ◽  
Influenza A ◽  
H1n1 Virus ◽  
Influenza A H1n1
Sign in / Sign up

Export Citation Format

Share Document